Read the latest insights on emerging CAR T therapies. This personalized treatment has shown promising results in certain types of cancers by harnessing the power of the immune system to fight disease.
Chimeric antigen receptor(CAR)-engineered natural killer (NK) cells designed with a CD28 costimulatory domain have superior anti-tumor efficacy and long-term cytotoxicity, research indicates.